In the BioHarmony Drug Report Database

"Preview" Icon

Clotrimazole

Gyne-lotrimin, Gyne-lotrimin 3 Combination Pack, Gyne-lotrimin Combination Pack, Lotrimin, Mycelex, Mycelex-7 Combination Pack, Mycelex-g, Trivagizole (clotrimazole) is a small molecule pharmaceutical. Clotrimazole was first approved as Gyne-lotrimin on 1982-01-01. It is used to treat cutaneous candidiasis, mycoses, oral candidiasis, tinea pedis, and vulvovaginal candidiasis in the USA. It is known to target intermediate conductance calcium-activated potassium channel protein 4, transient receptor potential cation channel subfamily M member 2, transient receptor potential cation channel subfamily M member 4, transient receptor potential cation channel subfamily M member 8, nuclear receptor subfamily 1 group I member 3, and nuclear receptor subfamily 1 group I member 2.

 

Trade Name

 

Gyne-lotrimin, Gyne-lotrimin 3 Combination Pack, Gyne-lotrimin Combination Pack, Lotrimin, Mycelex, Mycelex-7 Combination Pack, Mycelex-g, Trivagizole
 

Common Name

 

clotrimazole
 

ChEMBL ID

 

CHEMBL104
 

Indication

 

cutaneous candidiasis, mycoses, oral candidiasis, tinea pedis, vulvovaginal candidiasis
 

Drug Class

 

Image (chem structure or protein)

Clotrimazole structure rendering